Position in GRAL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$385,315
+$93,634 QoQ
Shares Held
5,644
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#163
of 371 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $33,351,553 across 12 Diagnostics & Research names. GRAL ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
120,316 | $22,917,791 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
8,360 | $4,191,369 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
4,904 | $2,581,661 | |
| 4 | RVTY |
Revvity, Inc.
|
6,819 | $758,681 | |
| 5 | LH |
Labcorp Holdings Inc.
|
1,732 | $484,960 | |
| 6 | A |
Agilent Technologies, Inc.
|
2,983 | $396,231 | |
| 7 | NTRA |
Natera, Inc.
|
1,456 | $395,231 | |
| 8 | GRAL |
GRAIL, Inc.
This page
|
5,644 | $385,315 |
All Filings in GRAL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $385,315 | 5,644 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $291,681 | 5,644 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $483,069 | 5,644 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $333,788 | 5,645 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $290,214 | 5,644 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||